Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A library of cancer testis specific T cell receptors for T cell receptor gene therapy. | Mol Ther Oncolytics | 2023 | 36589698 | PubTator, text mining | PubMed |
| Advanced T and Natural Killer Cell Therapy for Glioblastoma. | J Korean Neurosurg Soc | 2023 | 36588388 | PubTator, text mining | PubMed |
| Retraction Notice to: LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells. | Mol Ther Nucleic Acids | 2023 | 36570675 | PubTator, text mining | PubMed |
| Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patients. | J Cancer Res Clin Oncol | 2023 | 36527482 | PubTator, text mining | PubMed |
| Nanoformulations targeting immune cells for cancer therapy: mRNA therapeutics. | Bioact Mater | 2023 | 36471724 | PubTator, text mining | PubMed |
| Lymphoma-associated mutations in autoreactive memory B cells of patients with Sjögren's syndrome. | J Pathol | 2023 | 36426826 | PubTator, text mining | PubMed |
| Cancer-testis gene STK31 is regulated by methylation and promotes the development of pancreatic cancer. | Cancer Med | 2023 | 36424885 | PubTator, text mining | PubMed |
| MET kinase inhibitor reverses resistance to entrectinib induced by hepatocyte growth factor in tumors with NTRK1 or ROS1 rearrangements. | Cancer Med | 2023 | 36416133 | PubTator, text mining | PubMed |
| Instigation of the epoch of nanovaccines in cancer immunotherapy. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2023 | 36410742 | PubTator, text mining | PubMed |
| The emerging field of oncolytic virus-based cancer immunotherapy. | Trends Cancer | 2023 | 36402738 | PubTator, text mining | PubMed |
| Engineered T cell therapy for viral and non-viral epithelial cancers. | Cancer Cell | 2023 | 36400016 | PubTator, text mining | PubMed |
| Cellular Cancer Immunotherapy Development and Manufacturing in the Clinic. | Clin Cancer Res | 2023 | 36383184 | PubTator, text mining | PubMed |
| SARS-CoV-2 Spike protein suppresses CTL-mediated killing by inhibiting immune synapse assembly. | J Exp Med | 2023 | 36378226 | PubTator, text mining | PubMed |
| Redirecting Polyclonal T Cells against Cancer with Soluble T-Cell Receptors. | Clin Cancer Res | 2023 | 36255733 | PubTator, text mining | PubMed |
| Lung cancer and oncolytic virotherapy--enemy's enemy. | Transl Oncol | 2023 | 36244134 | PubTator, text mining | PubMed |
| Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell-like Program Conserved in HPV-Positive Cancers. | Cancer Discov | 2023 | 36213965 | PubTator, text mining | PubMed |
| Lipid-based nucleic acid therapeutics with in vivo efficacy. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2023 | 36180107 | PubTator, text mining | PubMed |
| Physical-Chemical Regulation of Membrane Receptors Dynamics in Viral Invasion and Immune Defense. | J Mol Biol | 2023 | 36007627 | PubTator, text mining | PubMed |
| Machine learning algorithm-generated and multi-center validated melanoma prognostic signature with inspiration for treatment management. | Cancer Immunol Immunother | 2023 | 35998003 | PubTator, text mining | PubMed |
| Therapeutic targeting of PRAME with mTCRCAR T cells in acute myeloid leukemia. | Blood Adv | 2023 | 35984639 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=17